|Min SIP Amount||₹500|
|NAV||₹19.28 (22 Jan 2021)|
|Fund Started||30 Nov 2018|
|Fund Size||₹1,043 Cr|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||8.3%|
|Ipca Laboratories Ltd.||Healthcare||Equity||8.3%|
|Divi's Laboratories Ltd.||Healthcare||Equity||6.2%|
|Procter & Gamble Health Ltd.||Healthcare||Equity||5.6%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||5.0%|
|Apollo Hospitals Enterprise Ltd.||Healthcare||Equity||4.9%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||3.8%|
|Max Healthcare Institute Ltd.||Healthcare||Equity||3.6%|
DSP Healthcare Fund Regular Dividend is a Equity Mutual Fund Scheme launched by DSP Mutual Fund. This scheme was made available to investors on 30 Nov 2018. Aditya Khemka is the Current Fund Manager of DSP Healthcare Fund Regular Dividend fund.The fund currently has an Asset Under Management(AUM) of ₹1,043 Cr and the Latest NAV as of 22 Jan 2021 is ₹19.28.
The DSP Healthcare Fund Regular Dividend is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 500. Exit load of 1% if redeemed within 12 months.
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.